Lacosamide Accord (Lacosamide)

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilising hyper‑excitable neuronal membranes. This reduces the ability of neurons to fire repetitively, thereby limiting seizure propagation without markedly affecting normal neuronal activity.

The specific dose of Lacosamide Accord is determined by the prescribing clinician based on the patient’s age, renal function, concomitant medications and seizure control needs. Dosage titration follows established clinical guidelines.

The safety of lacosamide in pregnancy and lactation has not been fully established. Healthcare providers should evaluate the potential benefits against possible risks and discuss treatment options with the patient.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lacosamide belongs to the sodium channel blocker class, offering a distinct mechanism that enhances slow inactivation of sodium channels. Compared with other agents like carbamazepine or phenytoin, it may have a lower risk of drug‑induced hyponatraemia and is often better tolerated in patients who experience cognitive side effects with older sodium blockers.

Lacosamide Accord should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and excessive heat to maintain its stability.

Lacosamide Accord is taken orally, usually as a tablet, with or without food. The prescribing physician will provide instructions on the dosing schedule and any necessary titration steps.

Serious risks include cardiac conduction abnormalities such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and the emergence of suicidal thoughts or behaviours. Patients should be monitored regularly for these events, especially during dose adjustments.

Lacosamide Accord is contraindicated in patients with known hypersensitivity to lacosamide or any of its excipients. Caution is advised for individuals with significant cardiac conduction disorders, severe hepatic impairment, or those taking medications that may cause dangerous additive effects.